U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
101221101221Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B)CompletedNo Results AvailableDiabetesDrug: BMS-903452|Drug: BMS-903452|Drug: BMS-903452|Drug: BMS-903452|Drug: BMS-903452|Drug: BMS-903452|Drug: BMS-903452|Drug: Placebo|Drug: Placebo|Drug: BMS-903452|Drug: BMS-903452|Drug: Placebo|Drug: BMS-903452|Drug: BMS-903452|Drug: BMS-903452https://ClinicalTrials.gov/show/NCT01240980
101222101222To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal FunctionCompletedNo Results AvailableHealthy Volunteers|Patients|Pharmacokinetics|Renal ImpairmentDrug: TC-5214https://ClinicalTrials.gov/show/NCT01240967
101223101223Comparison of Different Up-dosing Schedules With OsirisTerminatedNo Results AvailableAllergic RhinitisDrug: OSIRIS|Drug: OSIRIS other concentration 1|Drug: OSIRIS other concentration 2https://ClinicalTrials.gov/show/NCT01240954
101224101224Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast CancerWithdrawnNo Results AvailableMetastatic Breast CancerDrug: MK-2206|Drug: Exemestane|Drug: Goserelinhttps://ClinicalTrials.gov/show/NCT01240941
101225101225MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast CancerWithdrawnNo Results AvailableMetastatic Breast CancerDrug: MSK-2206|Drug: Exemestane|Drug: Goserelinhttps://ClinicalTrials.gov/show/NCT01240928
101226101226A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative ColitisCompletedNo Results AvailableColitis, UlcerativeDrug: placebo|Drug: MultiStem low dose|Drug: placebo|Drug: MultiStem low dose|Drug: placebo|Drug: MultiStem high dose|Drug: placebo|Drug: MultiStem high dose|Drug: placebo|Drug: MultiStem high dose|Drug: placebo|Drug: MultiStem high dosehttps://ClinicalTrials.gov/show/NCT01240915
101227101227Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve ReplacementActive, not recruitingHas ResultsSevere Aortic StenosisDevice: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)|Device: Surgical Aortic Valve Replacement (SAVR)https://ClinicalTrials.gov/show/NCT01240902
101228101228Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*CompletedNo Results AvailableAllergyDrug: Fluticasone|Drug: Fluticasonhttps://ClinicalTrials.gov/show/NCT01240889
101229101229Study to Evaluate the Safety and Efficacy of CEP-37247 Administered by the Transforaminal Epidural Route for the Treatment of Patients With Lumbosacral Radicular Pain Associated With Disk HerniationCompletedNo Results AvailableSciaticaDrug: CEP-37247|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01240876
101230101230Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of TimeCompletedNo Results AvailablePainDrug: Hydrocodone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01240863
101231101231Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter TrialRecruitingNo Results AvailableIdiopathic Retroperitoneal Fibrosis|Perianeurysmal Retroperitoneal Fibrosis|Chronic PeriaortitisDrug: Methotrexate+Prednisone|Drug: Prednisonehttps://ClinicalTrials.gov/show/NCT01240850
101232101232Effect of Palm Sugar on Blood Glucose ConcentrationsCompletedNo Results AvailableHealthy AdultsOther: Arenga Pinnata Sugar|Other: Glucose|Other: Sucrosehttps://ClinicalTrials.gov/show/NCT01240837
101233101233Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder CancerCompletedNo Results AvailableBladder CancerDrug: aminophyllinehttps://ClinicalTrials.gov/show/NCT01240824
101234101234Study of Immune Cell Changes in the Genital Tract 2 Months After Initiation of an IUD for ContraceptionCompletedHas ResultsGenital Tract Mucosal Immunity|Genital Tract MicrofloraDrug: IUD placement|Drug: Levonorgestrel IUD|Drug: Copper T380A IUDhttps://ClinicalTrials.gov/show/NCT01240811
101235101235Depression and Anxiety in the Aetiology and Prognosis of Specific Cardiovascular Disease Syndromes: a CALIBER StudyActive, not recruitingNo Results AvailableDepression|Anxiety|Coronary Disease|Cardiovascular Diseasehttps://ClinicalTrials.gov/show/NCT01240798
101236101236Metformin Versus Insulin in Gestational DiabetesCompletedHas ResultsGestational DiabetesDrug: metformin|Drug: insulinhttps://ClinicalTrials.gov/show/NCT01240785
101237101237Randomized Controlled Trial Comparing Transanal Doppler-guided Arterial Ligation With Mucopexy and Stapled HaemorrhoidopexyCompletedNo Results AvailableSymptomatic Haemorrhoidal Disease Requiring Surgical ManagementDevice: doppler-guided arterial ligation with mucopexy|Device: stapled haemorrhoidopexy according to Longohttps://ClinicalTrials.gov/show/NCT01240772
101238101238Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin TherapyCompletedNo Results AvailableType 2 Diabetes MellitusDrug: S-707106 dose 1|Drug: S-707106 dose 2|Drug: S-707106 dose 3|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01240759
101239101239Study of Quadrivalent Influenza Vaccine Among ChildrenCompletedHas ResultsInfluenzaBiological: Licensed 2010-2011 Trivalent Influenza Vaccine, No Preservative|Biological: Investigational Trivalent Influenza Vaccine with alternate B strain, No Preservative|Biological: Quadrivalent Influenza Vaccine, No Preservativehttps://ClinicalTrials.gov/show/NCT01240746
101240101240[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01240733
101241101241A Dose Finding and Efficacy Study of the Tumour Targeting Human 131I-F16SIP Monoclonal Antibody in Patients With CancerCompletedNo Results AvailableCancerDrug: 131I-F16SIP Radioimmunotherapy (RIT)https://ClinicalTrials.gov/show/NCT01240720
101242101242Pathophysiologic Changes in the Respiratory System After Fire Smoke InhalationRecruitingNo Results AvailableBronchial AsthmaOther: Fiberoptic bronchoscopyhttps://ClinicalTrials.gov/show/NCT01240707
101243101243A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Patients With Systemic Lupus ErythematosusTerminatedNo Results AvailableSystemic Lupus ErythematosusDrug: CEP-33457https://ClinicalTrials.gov/show/NCT01240694
101244101244Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI) and Fluorothymidine Positron Emission Tomography (FLT PET) in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant ChemotherapyCompletedNo Results AvailableLocally Advanced Breast Cancer (LABC)Procedure: FLT PET and BOLD MRI scanhttps://ClinicalTrials.gov/show/NCT01240681
101245101245Hyponatremia Registry for Patients With Euvolemic and Hypervolemic HyponatremiaCompletedNo Results AvailableEuvolemic Hyponatremia|Hypervolemic Hyponatremiahttps://ClinicalTrials.gov/show/NCT01240668
101246101246A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid TumorsCompletedNo Results AvailableSolid TumorsDrug: LCL161|Drug: Paclitaxelhttps://ClinicalTrials.gov/show/NCT01240655
101247101247An Open-label, Dose Escalation Multi-center Study in Patients With Advanced Cancer to Determine the Infusion Rate Effect of ASA 404 With Paclitaxel Plus Carboplatin Regimen or Docetaxel on the Pharmacokietics of Free and Total ASA404TerminatedNo Results AvailableMetastatic Cancer With Impaired Renal Function|Metastatic Cancer With Normal Renal FunctionDrug: ASA404https://ClinicalTrials.gov/show/NCT01240642
101248101248Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate CancerSuspendedNo Results AvailableProstate Cancer|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate CancerOther: laboratory biomarker analysis|Other: questionnaire administration|Drug: doxorubicin-GnRH agonist conjugate AEZS-108https://ClinicalTrials.gov/show/NCT01240629
101249101249Nicotinic Modulation of the Default Network of Resting Brain FunctionCompletedNo Results AvailableNicotine Dependencehttps://ClinicalTrials.gov/show/NCT01240616
101250101250Plasmodium Falciparum Clearance Rates in Response to Artesunate in Eastern CambodiaCompletedNo Results AvailableMalariahttps://ClinicalTrials.gov/show/NCT01240603

* Görseller ve İçerik tekif hakkına sahip olabilir